The GMO Emerging Markets Strategy seeks total return in excess of that of its benchmark, the MSCI Emerging Markets Index. GMO uses proprietary quantitative techniques and fundamental analysis to evaluate and select countries, sectors, and equity investments based on factors including, but not limited to, valuation, quality, patterns of price movement and volatility, macroeconomic factors, and ESG (environmental, social and governance) criteria. GMO expects the Strategy will have a value bias relative to its benchmark.


Arjun Divecha and Warren Chiang introduce Emerging Markets investing at GMO and discuss what makes our particular strategy so compelling to equity investors. View the webinar.

Download the transcript.






Fact Sheet Download
Product Primer Download
GIPS® Composite Report Download
Composite Descriptions Download
Download All Download


Performance Download
Portfolio Composition Download
Download All Download

Commentary & Attribution

Commentary Quarterly Download
Year-End Letter Download
Attribution - Monthly Download
Attribution - Quarterly Download
Attribution - YTD Download
Download All Download


Risks associated with an investment in the Strategy may include Market Risk - Equities, Non-U.S. Investment Risk, Currency Risk, Management and Operational Risk, and Illiquidity Risk.

Related Reading

Read More GMO Research